Generate Biomedicines aims to raise $425 million in US IPO

- Drug developer Generate Biomedicines said on Monday it was aiming to raise as much as $425 million in its initial public offering in the United States.


Every question you ask will be answered
Scan the QR code to contact us
whatsapp
Also you can contact us via